These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 25242509

  • 21. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S.
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-128 promotes cell-cell adhesion in U87 glioma cells via regulation of EphB2.
    Lin L, Chen X, Peng X, Zhou J, Kung HF, Lin MC, Jiang S.
    Oncol Rep; 2013 Sep; 30(3):1239-48. PubMed ID: 23835497
    [Abstract] [Full Text] [Related]

  • 23. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells.
    Laurila EM, Sandström S, Rantanen LM, Autio R, Kallioniemi A.
    Genes Chromosomes Cancer; 2012 Jun; 51(6):557-68. PubMed ID: 22344632
    [Abstract] [Full Text] [Related]

  • 24. miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.
    Zhang Y, Zheng D, Xiong Y, Xue C, Chen G, Yan B, Ye Q.
    FEBS Lett; 2014 May 21; 588(10):1913-20. PubMed ID: 24704686
    [Abstract] [Full Text] [Related]

  • 25. miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A.
    Yang H, Li Q, Zhao W, Yuan D, Zhao H, Zhou Y.
    FEBS Lett; 2014 Jan 03; 588(1):192-7. PubMed ID: 24316513
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.
    J Urol; 2013 Sep 03; 190(3):1059-68. PubMed ID: 23454155
    [Abstract] [Full Text] [Related]

  • 27. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K.
    J Gastroenterol Hepatol; 2013 Mar 03; 28(3):565-75. PubMed ID: 22989374
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y, Tang Q, Li M, Jiang S, Wang X.
    Biochem Biophys Res Commun; 2014 Feb 07; 444(2):199-204. PubMed ID: 24440701
    [Abstract] [Full Text] [Related]

  • 29. miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1.
    Tian S, Guo X, Yu C, Sun C, Jiang J.
    Oncotarget; 2017 Feb 14; 8(7):11071-11082. PubMed ID: 28052003
    [Abstract] [Full Text] [Related]

  • 30. Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1.
    Bell RE, Khaled M, Netanely D, Schubert S, Golan T, Buxbaum A, Janas MM, Postolsky B, Goldberg MS, Shamir R, Levy C.
    J Invest Dermatol; 2014 Feb 14; 134(2):441-451. PubMed ID: 23934065
    [Abstract] [Full Text] [Related]

  • 31. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
    Goto Y, Nishikawa R, Kojima S, Chiyomaru T, Enokida H, Inoguchi S, Kinoshita T, Fuse M, Sakamoto S, Nakagawa M, Naya Y, Ichikawa T, Seki N.
    FEBS Lett; 2014 May 21; 588(10):1973-82. PubMed ID: 24768995
    [Abstract] [Full Text] [Related]

  • 32. miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase.
    Orlandella FM, Mariniello RM, Mirabelli P, De Stefano AE, Iervolino PLC, Lasorsa VA, Capasso M, Giannatiempo R, Rongo M, Incoronato M, Messina F, Salvatore M, Soricelli A, Salvatore G.
    Br J Cancer; 2020 Aug 21; 123(3):426-437. PubMed ID: 32418991
    [Abstract] [Full Text] [Related]

  • 33. Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD.
    Kim H, Choi H, Lee SK.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):733-42. PubMed ID: 25449437
    [Abstract] [Full Text] [Related]

  • 34. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL, Wang J, Zhao ZJ, Liu N, Wang AL, Ren HY, Yang F, Diao KX, Fu WN, Wan EH, Mi XY.
    Oncol Rep; 2014 May 28; 31(5):2085-92. PubMed ID: 24677135
    [Abstract] [Full Text] [Related]

  • 35. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
    Hamada S, Satoh K, Fujibuchi W, Hirota M, Kanno A, Unno J, Masamune A, Kikuta K, Kume K, Shimosegawa T.
    Mol Cancer Res; 2012 Jan 28; 10(1):3-10. PubMed ID: 22064652
    [Abstract] [Full Text] [Related]

  • 36. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H, An H, Wang B, Liao Q, Li W, Jin X, Cui S, Zhang Y, Ding Y, Zhao L.
    Eur J Cancer; 2013 Dec 28; 49(18):3924-35. PubMed ID: 23968734
    [Abstract] [Full Text] [Related]

  • 37. miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma.
    Fu TG, Wang L, Li W, Li JZ, Li J.
    Int J Mol Med; 2016 Jun 28; 37(6):1627-35. PubMed ID: 27081712
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA‑296 targets AKT2 in pancreatic cancer and functions as a potential tumor suppressor.
    Li H, Li J, Shi B, Chen F.
    Mol Med Rep; 2017 Jul 28; 16(1):466-472. PubMed ID: 28534950
    [Abstract] [Full Text] [Related]

  • 39. MiR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151.
    Wang X, Yu H, Lu X, Zhang P, Wang M, Hu Y.
    Biochem Biophys Res Commun; 2014 Feb 28; 445(1):175-9. PubMed ID: 24495805
    [Abstract] [Full Text] [Related]

  • 40. MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK.
    Qin J, Luo M.
    FEBS Lett; 2014 Jan 03; 588(1):99-104. PubMed ID: 24269686
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.